Pre-clinical assessment of SAR442257, a CD38/CD3xCD28 trispecific T cell engager in treatment of relapsed/refractory multiple myeloma - Grab, Anna Luise; Kim, Peter S.; John, Lukas; Bisht, Kamlesh; Wang, Hongfang; Baumann, Anja; Van de Velde, Helgi; Sarkar, Irene; Shome, Debarati; Reichert, Philipp; Manta, Calin-Petru; Gryzik, Stefanie; et al. (Cells, 2024)
Gesehen am 12.06.2025